Gerharz, EW;Gschwend, JE
Standing the test of time: long-term results of standard procedures in urology
World J Urol
2006
24
3
229-230

Maier, C;Vesovic, Z;Bachmann, N;Herkommer, K;Braun, AK;Surowy, HM;Assum, G;Paiss, T;Vogel, W
Germline mutations of the MSR1 gene in prostate cancer families from Germany.
Hum Mutat
2006
27
1
98-102

Hesse, A;Straub, M
Rational evaluation of urinary stone disease.
Urol Res
2006
34
2
126-30

Hebbring, SJ;Fredriksson, H;White, KA;Maier, C;Ewing, C;McDonnell, SK;Jacobsen, SJ;Cerhan, J;Schaid, DJ;Ikonen, T;Autio, V;Tammela, TL;Herkommer, K;Paiss, T;Vogel, W;Gielzak, M;Sauvageot, J;Schleutker, J;Cooney, KA;Isaacs, W;Thibodeau, SN
Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
Cancer Epidemiol Biomarkers Prev
2006
15
5
935-8

Kuefer, R;Autenrieth, M;Herkommer, K;Blum, P;Merseburger, A;Hofer, M;Rinnab, L;Gschwend, J;Ringhoffer, M
[Translational research in renal cell cancer. Illustrated by the example of the vascular endothelial growth factor pathway]
Urologe A
2006
45
3
328, 330-5

Schwaibold, HE;Sivalingam, S;May, F;Hartung, R
The value of a second transurethral resection for T1 bladder cancer.
BJU Int
2006
97
6
1199-201

May, F;Hartung, R
Surgical atlas. Transurethral resection of the prostate.
BJU Int
2006
98
4
921-34

Straub, M;Hautmann, RE
[Kein Titel angegeben]
Urologe A
2006
45
11
1385-1386

Straub, M;Hautmann, RE
[Evidence-based pharmacological metaphylaxis of stone disease.]
Urologe A
2006
45
11
1399-1405

Straub, M
[What kind of stone prevention for whom? : Risk-adjusted metaphylaxis following urinary stone disease.]
Urologe A
2006
45
11
1387-1391